Secondary menu
-
Careers
Header persistent submenu
-
Investors
Learn about our strategy, sales and results or download our investor seminar presentations.
Header persistent submenu
-
Media
Come here for news, press releases, statements and other multi-media content about Nestlé.
Header persistent submenu
Header persistent submenu
Our commitment
We are committed to using our capabilities and expertise to tackle health challenges including diabetes and other non-communicable diseases.
By working with partners like the International Diabetes Federation, we believe we can build awareness and promote healthy lifestyles through balanced nutrition and physical activity.
Nestlé Health Science is engaged in elevating and expanding the role of nutrition in the healthcare systems approach to acute and chronic medical conditions. Metabolic Health – including obesity and diabetic neuropathy – is one of six areas of focus, including Ageing Medical Care, Critical Care and Surgery, Paediatric Medical Care, Gastrointestinal Health and Brain Health.
Visit the Nestlé stand at the congress to find out more.
The Nestlé Nutrition Institute will sponsor a satellite symposium on Thursday 5 December.
Nutritional Management of Obesity in Diabetes - an Outlook Into the Future (pdf, 207 Kb)

Nestlé Health Science products aimed at addressing obesity and diabetic neuropathy:
Optifast products are low glycemic index, making them suitable for managing obesity in people with diabetes.
Metanx is a medical food dispensed by prescription for the clinical dietary management of endothelial dysfunction in patients with diabetic peripheral neuropathy.

